It makes people think about what's worth spending money on and what isn't.
GOP members of Congress should deal transparently with their health insurance subsidies.
Let us focus on a larger reality: Professor Gruber practices rather poor economics.
The FDA needs to complete its approval process for generic versions of biologic drugs.
Everything with politics today seems to be black or white, red or blue. But there's at least one issue that falls in between.
It is time to refute all the arguments against active dying.
A program identifying Medicare billing errors, overpayments and underpayments is under attack.
Hospitals need to take greater precautions to protect workers.
But many ObamaCare revenues belong on an "endangered" list.
Klain will help the American people understand what is happening, and not happening, and why.